Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

1 In this article, we explore the impact of incretin-mimetic drugs on muscle health and what can be done to limit these severe side effects. Incretins are intestinal hormones secreted in response to ...

Each person probably has a visceral fat threshold that is genetically determined. Incretin mimetics — GLP-1 receptor agonists and GLP-1/GIP receptor agonists — are the first class of drugs to ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced receipt of revised regulatory ...

Ricks cited several reasons for the lower-than-expected sales of the incretin mimetics, engineered peptides that work by mimicking gut hormones. December sales usually outperform the rest of the ...

Opens in a new tab or window We have very little data right now to answer the question of whether we should be using a GLP-1 or GLP agonist and incretin mimetic during or even after cancer therapy.